News

The results showed improvement in the primary end point, which was defined as a reduction in facial erythema, over an eight hour period in patients with erythematotelangiectatic rosacea

The compounds are Boehringer Ingelheim‘s two oral diabetes agents – linagliptin and BI10773 as well as Lilly‘s two basal insulin analogues – LY2605541 and LY2963016. The agreement also

Merck said that the extended release formulation of Janumet is composed with sitagliptin, Januvia’s (sitagliptin) active component and metformin extended release, which is a treatment for type 2

Sinopharm, which has 16 wholly owned subsidiaries, has core business in pharmaceutical distribution, scientific research and manufacturing of medical and biotech products. Sinopharm will acquire the shares through

SamplesTogether will be powered by One Eleven’s SampleServer, e-sampling toolset used in pharmaceutical industry. SamplesTogether helps the pharmaceutical companies to optimize their sampling efforts by giving prescribers secure

The system’s workflow provides the flexibility to analyze data in as few as eight hours, or to generate in excess of 1 gigabase per run in slightly over

The company has also dosed first patient in the trial. The trial is designed to investigate the safety and escalating doses of OMP-59R5 in patients who have received

Sumavel DosePro is indicated for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache. Sumavel DosePro is a pre-filled, single-use

Ranibizumab, approved in UK as a treatment for wet age-related macular degeneration (AMD) under the brand name Lucentis. Ranibizumab was developed by Genentech and Novartis. Genentech has the